BE843691A - Procede pour la preparation de chlorhydrate de4' -chloro-23-(10,11-dihydro-5h)dibenz(b,f) azepinyl-(5)-propyl -methylamino - acetophenone (ou chlorhydrate de lofepramine) - Google Patents

Procede pour la preparation de chlorhydrate de4' -chloro-23-(10,11-dihydro-5h)dibenz(b,f) azepinyl-(5)-propyl -methylamino - acetophenone (ou chlorhydrate de lofepramine)

Info

Publication number
BE843691A
BE843691A BE168562A BE168562A BE843691A BE 843691 A BE843691 A BE 843691A BE 168562 A BE168562 A BE 168562A BE 168562 A BE168562 A BE 168562A BE 843691 A BE843691 A BE 843691A
Authority
BE
Belgium
Prior art keywords
lofepramino
chlorhydrate
dibenz
azepinyl
acetophenone
Prior art date
Application number
BE168562A
Other languages
English (en)
French (fr)
Inventor
E Eriksoo
S S Kelfve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE843691A publication Critical patent/BE843691A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
BE168562A 1975-07-03 1976-07-01 Procede pour la preparation de chlorhydrate de4' -chloro-23-(10,11-dihydro-5h)dibenz(b,f) azepinyl-(5)-propyl -methylamino - acetophenone (ou chlorhydrate de lofepramine) BE843691A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28145/75A GB1497306A (en) 1975-07-03 1975-07-03 Preparation of lofepramine and its hydrochloride

Publications (1)

Publication Number Publication Date
BE843691A true BE843691A (fr) 1977-01-03

Family

ID=10270996

Family Applications (1)

Application Number Title Priority Date Filing Date
BE168562A BE843691A (fr) 1975-07-03 1976-07-01 Procede pour la preparation de chlorhydrate de4' -chloro-23-(10,11-dihydro-5h)dibenz(b,f) azepinyl-(5)-propyl -methylamino - acetophenone (ou chlorhydrate de lofepramine)

Country Status (10)

Country Link
US (1) US4172074A (de)
JP (1) JPS6014030B2 (de)
BE (1) BE843691A (de)
CA (1) CA1079274A (de)
CH (1) CH618686A5 (de)
DE (1) DE2628558A1 (de)
FR (1) FR2316234A1 (de)
GB (1) GB1497306A (de)
IE (1) IE43255B1 (de)
SE (1) SE7607565L (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108119A1 (de) * 1991-03-13 1992-09-17 Jellalabad Ltd Verfahren zur herstellung von 4'-chlor-2-((3-(10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl) methylaminno) acetophenon und seiner salze, die stabilisierungseiner salze, hierbei erhaeltliche produkte und pharmmazeutische zubereitungen, die diese enthalten
JPH10508583A (ja) * 1994-10-05 1998-08-25 カリ ロダー Ｌ−フェニルアラニン、チロシン又はトリプトファン、及びでき得ればビタミンｂ▲下１２▼を配合したロフェプラミンを使用する多発性硬化症及びその他の脱髄性状態の治療
GB2308065B (en) * 1994-10-05 1999-01-13 Cari Loder Treatment of multiple sclerosis (MS) and other demyelinating conditions
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
AU2005290980A1 (en) * 2004-10-01 2006-04-13 Neurocure Ltd Use of pharmaceutical compositions of lofepramine for the treatment of ADHD, CFS, FM and depression
EP2317316A3 (de) 2005-07-08 2011-06-15 Braincells, Inc. Verfahren zur Identifizierung von neurogenesemodulierenden Wirkstoffen und Bedingungen
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2377531A2 (de) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
EP2026813A2 (de) 2006-05-09 2009-02-25 Braincells, Inc. 5-ht-rezeptor-vermittelte neurogenese
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
WO2008086483A2 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1177525A (en) * 1967-04-13 1970-01-14 Leo Ab New Heterocyclic Aminoketones of Therapeutic Interest

Also Published As

Publication number Publication date
IE43255L (en) 1977-01-03
IE43255B1 (en) 1981-01-14
FR2316234B1 (de) 1979-06-08
FR2316234A1 (fr) 1977-01-28
CA1079274A (en) 1980-06-10
JPS6014030B2 (ja) 1985-04-11
CH618686A5 (de) 1980-08-15
SE7607565L (sv) 1977-01-04
GB1497306A (en) 1978-01-05
DE2628558C2 (de) 1989-11-16
DE2628558A1 (de) 1977-01-20
JPS527982A (en) 1977-01-21
US4172074A (en) 1979-10-23

Similar Documents

Publication Publication Date Title
PT68573A (fr) Procede de preparation des derivatifs d'imidazole.
RO76889A (ro) Procedeu de preparare a unor 8-metoximetilergoline sau 8-metilmercaptometilergoline
RO68479A (ro) Procedeu pentru prepararea unor 1,4-dihidropiridincarboxilati de aralchil
RO81173A (ro) Procedeu pentru prepararea unor derivati de delta2-1,2,4-triazolin-5-ona
BE843691A (fr) Procede pour la preparation de chlorhydrate de4' -chloro-23-(10,11-dihydro-5h)dibenz(b,f) azepinyl-(5)-propyl -methylamino - acetophenone (ou chlorhydrate de lofepramine)
BE875183A (fr) Procede pour la preparation de 2,2,6,6-tetramethyl-4-piperidone.
RO76562A (fr) Procede pour la preparation des 3-imidazolilbenzo-1,2,4-triazine-1-oxydes
RO69608A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazol-3-one
BE884650A (fr) Procede pour la preparation de diesterdiamides
BE885977A (fr) Procede pour la preparation de dithiazolyldisulfures
BE838823A (fr) Procede pour la preparation de 1,2,5-dihydroxycholecalciferol
RO78225A (ro) Procedeu pentru prepararea unor 3,4-dihidro-3-oxo-2-chinoxaline
BE855221A (fr) Procede de preparation d'organopolysiloxanes
RO79048A (ro) Procedeu pentru prepararea unor derivati de 5,11-dihidro-6h-pirido-(2,3b)-(1,4)-benzodiazepin-6-ona
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
PT68686A (fr) Proces pour la production de 2,6-diamynonebularines
FR2300059A1 (fr) Procede pour la preparation de 2,5-dichloro-p-xylene
LU80567A1 (fr) Procede pour la preparation de 3-iodo-et de 3 bromorifamycine s
BE880509A (fr) Procede de preparation de 2',6'-dialkyl-n-alcoxymethyl-2-chloro-acetanilides
RO75387A (ro) Procedeu pentru prepararea unor derivatidde 4"-aminooleandomicina
RO76667A (ro) Procedeu pentru prepararea unor 2,4-dialchilamino-6-clor-5-triazine
BE845327A (fr) Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes
BE880031A (fr) Procede pour la preparation de 1 alpha, 3 beta-dihydroxy-delta 5-steroides
BE867414A (fr) Procede pour la preparation d'hydroxy-alpha-aminobenzylpenicillines
BE867228A (fr) Procede pour la preparation d'hydroxyphenylglycocolles

Legal Events

Date Code Title Description
CN Change of patent owner's name
RE20 Patent expired

Owner name: PHARMACIA BIOSYSTEMS A.B.

Effective date: 19960701